Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DeLorenzo, Christine
NCT04814355: The Effect of Celecoxib on Neuroinflammation in MDD	Recruiting	4	42	US	Celecoxib 400 mg, celebrex	Stony Brook University, Brain & Behavior Research Foundation	Major Depressive Disorder, Neuroinflammation	07/25	07/25
NCT04350567: Sleep/Wake Cycle and Depression: An Imaging and Treatment Study	Active, not recruiting	N/A	61	US	Sleep Deprivation	Stony Brook University	Depression; Major Depressive Disorder	05/25	05/25
Checkers, Alexandra
NCT04814355: The Effect of Celecoxib on Neuroinflammation in MDD	Recruiting	4	42	US	Celecoxib 400 mg, celebrex	Stony Brook University, Brain & Behavior Research Foundation	Major Depressive Disorder, Neuroinflammation	07/25	07/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DeLorenzo, Christine
NCT04814355: The Effect of Celecoxib on Neuroinflammation in MDD	Recruiting	4	42	US	Celecoxib 400 mg, celebrex	Stony Brook University, Brain & Behavior Research Foundation	Major Depressive Disorder, Neuroinflammation	07/25	07/25
NCT04350567: Sleep/Wake Cycle and Depression: An Imaging and Treatment Study	Active, not recruiting	N/A	61	US	Sleep Deprivation	Stony Brook University	Depression; Major Depressive Disorder	05/25	05/25
Checkers, Alexandra
NCT04814355: The Effect of Celecoxib on Neuroinflammation in MDD	Recruiting	4	42	US	Celecoxib 400 mg, celebrex	Stony Brook University, Brain & Behavior Research Foundation	Major Depressive Disorder, Neuroinflammation	07/25	07/25